September 2023 in “Journal of the European Academy of Dermatology and Venereology” This letter discusses the potential of the "Gabrin sign" as an indicator for identifying high-risk COVID-19 patients with androgenic alopecia, yet no specific results are detailed in the text.
3 citations
,
November 2020 in “Journal of The American Academy of Dermatology” This paper discusses the proposal that androgenetic alopecia, as seen in the "Gabrin sign", could indicate higher risk of severe COVID-19 symptoms, but its validity is questioned and further confirmation is needed.
2 citations
,
August 2020 in “Journal of The American Academy of Dermatology” This letter discusses existing research and encourages further studies on the relationship between androgenetic alopecia and COVID-19 severity, reporting no new clinical results.
February 2024 in “Indian Dermatology Online Journal” In this study, researchers at a tertiary care center reported a significant correlation between severe COVID-19 cases and the presence of androgenic alopecia, suggesting that androgen receptor expression may influence COVID-19 severity.
32 citations
,
July 2020 in “Journal of The American Academy of Dermatology” This study noted that among hospitalized COVID-19 patients, androgenetic alopecia was prevalent, and severe cases were associated with adverse outcomes such as respiratory failure, highlighting a possible link with androgen sensitivity.